CYTOFOTCPharmaceutical PreparationsFiscal year ends December 31
Altamira Therapeutics Ltd.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2025
$0.09+0.00 (0.00%)
Close on Oct 19, 2026
Dividends
Altamira Therapeutics has not reported a dividend
No dividend per share appears in Altamira Therapeutics's annual filings since fiscal 2014.